Harmonic (NASDAQ: HLIT) today announced it will release its first quarter 2025 financial results after the market close on ...

The Atlas-backed company plans to liquidate its assets, including an experimental drug for chronic spontaneous urticaria it ...

Third Harmonic Bio ( NASDAQ: THRD) will be liquidating the company and selling its remaining assets, the company said on ...

Third Harmonic Bio Inc (NASDAQ:THRD) shares are soaring on Monday after the company announced a plan of liquidation and dissolution.

Shares of Third Harmonic Bio, Inc. (THRD) drew investor attention on Monday after the company announced that its board of ...

Dell Technologies Inc. DELL climbed 5.8% to $86.73 in pre-market trading after the Trump administration excluded a range of ...

Third Harmonic Bio has abandoned plans to take its chronic spontaneous urticaria (CSU) drug into phase 2, instead preparing ...

Board of Directors has approved plan to liquidate and intends to seek stockholder approval for dissolution of the Company at the Annual Meeting ...